Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK

Autor:	Sagiv-Barfi, Idit, Kohrt, Holbrook E. K., Czerwinski, Debra K., Ng, Patrick P., Chang, Betty Y., Levy, Ronald
Zdroj:	Proceedings of the National Academy of Sciences of the United States of America, 2015 Mar 01. 112(9), E966-E972.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/26461721 Zobrazit plný text záznamu